Roivant Sciences Ltd. (ROIV) Q4 2025 Earnings Call Transcript
Roivant Sciences Ltd. reported its Q4 2025 earnings, revealing a loss per share of $0.32, which was slightly better than analysts' expectations. However, the company's revenue of $2.52 million represented a significant decline of 66.71% year-over-year, missing projections by $1.39 million. The earnings call featured insights from key executives and analysts discussing the company's performance and future outlook.
- ▪Roivant Sciences Ltd. reported an EPS of -$0.32, beating expectations by $0.03.
- ▪The company's revenue for Q4 2025 was $2.52 million, down 66.71% year-over-year.
- ▪Roivant's revenue missed analysts' expectations by $1.39 million.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4907040-roivant-sciences-ltd-roiv-q4-2025-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
